FLT1 and neoplasm: Angiogenesis is a critical process for tumorigenesis: inhibiting the activity of VEGFR1 or VEGFR3 reduces the proliferation of breast or colorectal cancer cell lines in vitro and inhibits tumor growth in vivo [33–36].